• Cy5 TSA Fluorescence System Kit for Astrocytes

  2026-09-09

  Translate transcriptomic astrocyte discoveries into spatially resolved validation with sensitive Cy5 detection in IHC, ICC, and FISH. This workflow is especially useful for regional, developmental, and cross-species comparisons where conventional fluorescence may miss scarce targets.

• TECPR1 Tubulation Repairs Lysosomes Under Energy Stress

  2026-09-09

  A 2026 Cell Research study identifies TECPR1 as a lysosomal membrane-repair factor that links PI4P-rich damaged lysosomes to KIF1A-driven membrane tubulation. The work connects this repair pathway with lipid metabolism, cell survival, and liver protection during energy stress, while providing a reconstituted membrane system for mechanistic analysis.

• Perifosine (KRX-0401) Experimental Workflow

  2026-09-08

  Perifosine (KRX-0401) enables a practical, pathway-centered workflow for Akt inhibition, apoptosis profiling, and radiation sensitization in cancer cells. This guide also shows how the compound can serve as a mechanistic contrast in Golgi-stress and ischemia/reperfusion assays without overstating evidence from neuroprotection models.

• Erastin: From Ferroptosis Mechanism to Translation

  2026-09-07

  Erastin is more than a laboratory death stimulus: it is a strategic probe for connecting oncogenic genotype, cystine metabolism, glutathione depletion, iron-dependent lipid damage, and translational biomarker design. This article explains how to deploy Erastin rigorously in ferroptosis research and cancer biology research.

• PF-562271 HCl: Reliable FAK/Pyk2 Assays

  2026-09-07

  This scenario-driven guide explains how PF-562271 HCl (SKU A8345) can improve the design and interpretation of cell viability, proliferation, and FAK phosphorylation assays. It covers formulation, concentration selection, orthogonal readouts, reversibility, and practical vendor-selection criteria for cancer research.

• SP600125 for Reliable JNK-Linked Cell Assays

  2026-09-05

  This scenario-based guide explains how SP600125, SKU A4604, can improve interpretation of cell viability, apoptosis, proliferation, and cytokine experiments by separating JNK-dependent signaling from nonspecific toxicity. It covers potency, controls, stock preparation, dose selection, data interpretation, and practical product-selection criteria.

• Neticonazole Hydrochloride: Applied Workflows

  2026-09-04

  Neticonazole Hydrochloride supports two distinct research tracks: membrane-focused antifungal assays and exploratory colorectal cancer studies centered on exosome release and apoptosis. This guide connects practical formulation, cell-based testing, and colon-targeted delivery concepts while separating established product information from hypothesis-generating workflows.

• IGF2BP1–TUBB4B Axis in Liver Fibrosis

  2026-09-04

  The reference study identifies an m6A-dependent IGF2BP1–TUBB4B–FAK pathway that promotes hepatic stellate cell activation, proliferation, and migration. Its integration of transcriptomic, RNA-binding, and functional perturbation data provides a mechanistic framework for connecting RNA stabilization with liver fibrogenesis and for designing pathway-level validation experiments.

• Erastin: A Practical Ferroptosis Research Workflow

  2026-09-03

  Build a controlled Erastin workflow for modeling oxidative, iron-dependent tumor cell death, from fresh DMSO stock preparation to orthogonal ROS, lipid-peroxidation, and mitochondrial readouts. The approach also shows how a soluble ferroptosis inducer can serve as a mechanistic benchmark for the folate-receptor-targeted nanoactivation strategy reported in pancreatic cancer.

• Leonurine Reframes Doxorubicin Cardiotoxicity

  2026-09-03

  The reference study identifies cardiac vascular endothelial cells as early sensors and amplifiers of doxorubicin-induced cardiomyopathy, linking endothelial cGAS–STING activation to NLRP3-dependent pyroptosis, pathogenic extracellular vesicles, and cardiomyocyte mitochondrial injury. It further characterizes leonurine as a direct STING inhibitor that binds Tyr261 and interrupts both STING oligomerization and STING–TBK1 complex formation, providing a mechanistic basis for endothelial-focused protection.

• Indometacin Sodium: Applied Research Workflows

  2026-09-02

  Indometacin Sodium Trihydrate combines non-selective COX inhibition with reported Wnt/β-catenin and GSK3β pathway activity, supporting inflammation, fibrosis, and myelin-repair workflows. This practical guide covers assay selection, dosing, controls, solubility, and troubleshooting while separating product-specific evidence from lessons borrowed from a randomized risedronate study.

• GW4064 for FXR Activation in Metabolic Research

  2026-09-02

  GW4064 is a selective, non-steroidal FXR agonist for connecting receptor activation with bile acid transport, lipid regulation, and hepatocyte barrier phenotypes. This workflow-focused guide covers dose design, LC-MS-compatible assays, controls, and troubleshooting for reliable metabolic and cholestasis research.

• Ridaforolimus: Practical mTOR Assay Workflows

  2026-09-01

  Ridaforolimus, also called Deforolimus, enables a layered workflow that connects mTOR phospho-signaling with proliferation, apoptosis assay readouts, and VEGF secretion. Its defined nanomolar activity makes it useful for cancer-cell profiling and for carefully controlled exploratory studies linking growth suppression with cellular senescence.

• Melatonin–Sacchachitin Hydrogel for Atopic Dermatitis

  2026-09-01

  A 2026 International Journal of Nanomedicine study developed a melatonin-loaded sacchachitin nanofiber hydrogel and evaluated it in a DNCB-induced NC/Nga mouse model of atopic dermatitis. The formulation reduced disease severity, epidermal hyperplasia, mast cell infiltration, and Th2-associated biomarkers while maintaining melatonin stability and hydrogel performance, supporting further investigation of a non-steroidal topical platform.

• From Omics to Spatial Proof in Metastatic HNSCC

  2026-08-31

  A translational perspective on converting metastatic HNSCC omic discoveries into spatially resolved evidence using HRP-mediated Cy5 tyramide amplification, with practical guidance for validation, assay selection, and clinical research strategy.

7891 records 1/527 page Next 12345 下5页 Last page